Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vemlidy for HBV Prophylaxis in Inflammatory Arthritis Patients
NCT05001672Phase 4Not yet recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Aug 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tenofovir alafenamide in hepatitis B virus infection, sponsored by Taipei Veterans General Hospital. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
tenofovir alafenamide
03
Conditions
hepatitis B virus infection
Beyond the preview
Go deeper on NCT05001672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05001672.